Viani et al (2012b) conducted a randomized trial of 200 patients (216 ptergium). The purpose of this trial was to evaluate a technique for reducing the recurrence of pterygium by using a low fractionation dose of 2 Gy (within 10 fractions) that would provide local control similar to that...
ERRunadj, and the ERRERRadj[V]adjusted for the confounding variableV. We categorized those estimates in which adjustment for potential confounders resulted in changes of the following magnitudes:
Patients were evaluated at 6 months for Body Image after Breast Cancer Questionnaire (BIBCQ) to assess possible changes in self-perception of body image and limitations. A 2nd questionnaire explored the impact of EBRT, IORT-f and IORT-b on resumption of work and normal daily activities. EBRT ...
Chrysin is a natural flavonoid with anti-cancer effects. Despite its beneficial effects, little information is available regarding its immunogenic cell death (ICD) properties. In this work, we hypothesized that chrysin can potentiate radiotherapy(RT)-ind
Under health damage, we thus understand enduring or intermittent irreversible changes of the physical, mental, and social functional capability of the person, which can arise from noxious influence developed over the short-term or long-term, or also from intense, short-term influences (e.g. ...
This design was implemented to avoid changes in any routine daily activities owing to the MF nonionizing radiation level being displayed. The level of MF exposure has been reported to be relatively stable when measured repeatedly over 12 to 26 months, and the study concluded that the measurement...
All Radiation Oncology coders are provided with changes and updates when they occur As part of our ongoing QA program, we audit a random sampling of each Radiation Oncology coder on a quarterly basis. Each Radiation Oncology coder must code at a 90% accuracy level or face dismissal. This allo...
ICD: Immunogenic cell death ROS: Reactive oxygen species TAAs: Tumor-associated antigens dsDNA: Double-stranded DNA DCs: Dendritic cells APCs: Antigen-presenting cells CTLs: Cytotoxic lymphocytes PRRs: Pattern recognition receptors TLR: Toll-like receptor MHC: Major histocompatibility compl...
Cancer incidence rates, grouped according to their ICD10 codes, have been collected and included in the program. Currently, the data set covers the period from 1995 to 2014, with rates being provided for each year. The ZfKD database does not include country-average incidence rates of non-...
Patients with ischemic or non-ischemic cardiomyopathy and recurrent sVA, with an ICD and history of ≥ 1 catheter ablation for sVA will be included. This is a prospective, multicenter, one-arm, dose-escalation trial utilizing the i3 + 3 design, a modified 3 + 3 specifically creat...